Indian Pharmacopoeia2026,10th Edition インド薬局方2026年版 第10版(全4巻)

インド薬局方2026, 第10版 - Indian Pharmacopoeia 2026, 10th Edition (全4巻)

欧州・英国等各国薬局方  > 




インド薬局方2026, 第10版 - Indian Pharmacopoeia 2026, 10th Edition (全4巻)

798,600(税込)

数量

書名

Indian Pharmacopoeia 2026, 10th Edition (4 Volume Set)
インド薬局方 2026年版, 第10版 (全4巻)
発行元 Indian Pharmacopoeia Commission
発行年/月 2026年1月   
装丁 Hardcover
発送予定 海外倉庫よりお取り寄せ3-5週間以内に発送致します
※本商品をご購入ご希望のお客様には下記エンドユーザー様情報のご提供をお願いしております。
全て英字にて、ご注文画面下部の備考欄にご記載ください。

<recipient>
Name:
Company name:
Company physical address:
E-mail address:
Tel: +81-
 

Description

 

Indian Pharmacopoeia (IP) is published by the Indian Pharmacopoeia Commission (IPC) on behalf of the Ministry of Health & Family Welfare, Government of India in fulfillment of the requirements of the Drugs and Cosmetics Act, 1940 and Rules 1945 thereunder. IP is recognized as the official book of standards for the drugs being manufactured and/or marketed in India. IP contains a collection of authoritative procedures of analysis and specifications of drugs for their identity, purity and strength. The standards of the IP are authoritative in nature and are enforced by the regulatory authorities for ensuring the quality of drugs in India. During quality assurance and at the time of dispute in the court of law the IP standards are legally acceptable.

What's New:

The Indian Pharmacopoeia 2026 incorporated 121 new monographs, increasing the total number of monographs to 3,340.

関連商品